Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Interleukin-1 receptor-associated kinase 4 | ||
Ligand | BDBM643863 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Potency of IRAK4 Inhibitor Compounds in IRAK4 Enzyme Assay | ||
IC50 | 0.700±n/a nM | ||
Citation | Terstiege, I; Schiesser, S; Xue, Y; Chang, H; Berggren, AI Substituted indazoles as IRAK4 inhibitors US Patent US11866405 Publication Date 1/9/2024 | ||
More Info.: | Get all data from this article, Assay Method | ||
Interleukin-1 receptor-associated kinase 4 | |||
Name: | Interleukin-1 receptor-associated kinase 4 | ||
Synonyms: | IRAK-4 | IRAK4 | IRAK4_HUMAN | Interleukin-1 receptor-associated kinase 4 (IRAK-4) | Interleukin-1 receptor-associated kinase 4 (IRAK4) | Renal carcinoma antigen NY-REN-64 | ||
Type: | Protein | ||
Mol. Mass.: | 51519.08 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q9NWZ3 | ||
Residue: | 460 | ||
Sequence: |
| ||
BDBM643863 | |||
n/a | |||
Name | BDBM643863 | ||
Synonyms: | US11866405, Example 114 | ||
Type | Small organic molecule | ||
Emp. Form. | C28H33N7O4 | ||
Mol. Mass. | 531.6061 | ||
SMILES | COc1cc2nn(cc2cc1C(=O)Nc1cnn2cccnc12)[C@@H]1CC[C@@H](CC1)N(C)C(=O)[C@@H]1CC[C@@H](O)C1 |r,wU:33.37,wD:23.26,26.33,36.41,(5.61,-9.99,;5.61,-8.45,;4.27,-7.68,;2.94,-8.45,;1.61,-7.68,;.14,-8.16,;-.76,-6.91,;.14,-5.66,;1.61,-6.14,;2.94,-5.37,;4.27,-6.14,;5.61,-5.37,;5.61,-3.83,;6.94,-6.14,;8.27,-5.37,;8.44,-3.84,;9.94,-3.52,;10.71,-4.85,;12.22,-5.17,;12.69,-6.64,;11.66,-7.78,;10.16,-7.46,;9.68,-6,;-2.3,-6.91,;-3.07,-8.24,;-4.61,-8.24,;-5.38,-6.91,;-4.61,-5.58,;-3.07,-5.58,;-6.92,-6.91,;-7.69,-5.58,;-7.69,-8.24,;-6.92,-9.58,;-9.23,-8.24,;-10.24,-7.08,;-11.66,-7.68,;-11.53,-9.21,;-12.69,-10.22,;-10.03,-9.56,)| | ||
Structure |